nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0387	0.291	CbGbCtD
Oxymorphone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.036	0.271	CbGbCtD
Oxymorphone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0165	0.124	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0162	0.122	CbGbCtD
Oxymorphone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0151	0.114	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0103	0.0777	CbGbCtD
Oxymorphone—Naltrexone—ABCB1—peripheral nervous system neoplasm	0.00221	0.325	CrCbGaD
Oxymorphone—Buprenorphine—ABCB1—peripheral nervous system neoplasm	0.00162	0.239	CrCbGaD
Oxymorphone—Naloxone—ABCB1—peripheral nervous system neoplasm	0.00161	0.237	CrCbGaD
Oxymorphone—Morphine—ABCB1—peripheral nervous system neoplasm	0.00136	0.2	CrCbGaD
Oxymorphone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00121	CcSEcCtD
Oxymorphone—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00121	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00121	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.0012	CcSEcCtD
Oxymorphone—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.0012	CcSEcCtD
Oxymorphone—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.0012	CcSEcCtD
Oxymorphone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00103	0.0012	CcSEcCtD
Oxymorphone—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00119	CcSEcCtD
Oxymorphone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00119	CcSEcCtD
Oxymorphone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00119	CcSEcCtD
Oxymorphone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00102	0.00119	CcSEcCtD
Oxymorphone—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00119	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00118	CcSEcCtD
Oxymorphone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00118	CcSEcCtD
Oxymorphone—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00101	0.00117	CcSEcCtD
Oxymorphone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00117	CcSEcCtD
Oxymorphone—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00117	CcSEcCtD
Oxymorphone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.001	0.00116	CcSEcCtD
Oxymorphone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.001	0.00116	CcSEcCtD
Oxymorphone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.001	0.00116	CcSEcCtD
Oxymorphone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000994	0.00116	CcSEcCtD
Oxymorphone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000988	0.00115	CcSEcCtD
Oxymorphone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000988	0.00115	CcSEcCtD
Oxymorphone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000986	0.00115	CcSEcCtD
Oxymorphone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000986	0.00115	CcSEcCtD
Oxymorphone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000985	0.00114	CcSEcCtD
Oxymorphone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000984	0.00114	CcSEcCtD
Oxymorphone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000982	0.00114	CcSEcCtD
Oxymorphone—Headache—Topotecan—peripheral nervous system neoplasm	0.000979	0.00114	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000978	0.00114	CcSEcCtD
Oxymorphone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000977	0.00114	CcSEcCtD
Oxymorphone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000977	0.00114	CcSEcCtD
Oxymorphone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000977	0.00114	CcSEcCtD
Oxymorphone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000976	0.00113	CcSEcCtD
Oxymorphone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000974	0.00113	CcSEcCtD
Oxymorphone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000973	0.00113	CcSEcCtD
Oxymorphone—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000973	0.00113	CcSEcCtD
Oxymorphone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000973	0.00113	CcSEcCtD
Oxymorphone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000971	0.00113	CcSEcCtD
Oxymorphone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000971	0.00113	CcSEcCtD
Oxymorphone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00097	0.00113	CcSEcCtD
Oxymorphone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000968	0.00113	CcSEcCtD
Oxymorphone—Pain—Vincristine—peripheral nervous system neoplasm	0.000968	0.00113	CcSEcCtD
Oxymorphone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000968	0.00113	CcSEcCtD
Oxymorphone—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000968	0.00113	CcSEcCtD
Oxymorphone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000968	0.00113	CcSEcCtD
Oxymorphone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000964	0.00112	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000961	0.00112	CcSEcCtD
Oxymorphone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000957	0.00111	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000956	0.00111	CcSEcCtD
Oxymorphone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000954	0.00111	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00095	0.0011	CcSEcCtD
Oxymorphone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000936	0.00109	CcSEcCtD
Oxymorphone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000934	0.00109	CcSEcCtD
Oxymorphone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000934	0.00109	CcSEcCtD
Oxymorphone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000929	0.00108	CcSEcCtD
Oxymorphone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000929	0.00108	CcSEcCtD
Oxymorphone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000928	0.00108	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000926	0.00108	CcSEcCtD
Oxymorphone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000925	0.00108	CcSEcCtD
Oxymorphone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000921	0.00107	CcSEcCtD
Oxymorphone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000921	0.00107	CcSEcCtD
Oxymorphone—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00091	0.00106	CcSEcCtD
Oxymorphone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000909	0.00106	CcSEcCtD
Oxymorphone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000909	0.00106	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.0009	0.00105	CcSEcCtD
Oxymorphone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000895	0.00104	CcSEcCtD
Oxymorphone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000895	0.00104	CcSEcCtD
Oxymorphone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000895	0.00104	CcSEcCtD
Oxymorphone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000893	0.00104	CcSEcCtD
Oxymorphone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000891	0.00104	CcSEcCtD
Oxymorphone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000887	0.00103	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000884	0.00103	CcSEcCtD
Oxymorphone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000874	0.00102	CcSEcCtD
Oxymorphone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00087	0.00101	CcSEcCtD
Oxymorphone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000867	0.00101	CcSEcCtD
Oxymorphone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000866	0.00101	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000864	0.001	CcSEcCtD
Oxymorphone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000857	0.000996	CcSEcCtD
Oxymorphone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000856	0.000995	CcSEcCtD
Oxymorphone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000843	0.00098	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000842	0.000979	CcSEcCtD
Oxymorphone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000834	0.00097	CcSEcCtD
Oxymorphone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000831	0.000966	CcSEcCtD
Oxymorphone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000825	0.000959	CcSEcCtD
Oxymorphone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000818	0.000951	CcSEcCtD
Oxymorphone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000818	0.000951	CcSEcCtD
Oxymorphone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000816	0.000948	CcSEcCtD
Oxymorphone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000812	0.000944	CcSEcCtD
Oxymorphone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000811	0.000943	CcSEcCtD
Oxymorphone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000806	0.000937	CcSEcCtD
Oxymorphone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000804	0.000935	CcSEcCtD
Oxymorphone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000797	0.000927	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000792	0.00092	CcSEcCtD
Oxymorphone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000792	0.00092	CcSEcCtD
Oxymorphone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000791	0.000919	CcSEcCtD
Oxymorphone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000784	0.000912	CcSEcCtD
Oxymorphone—Pain—Etoposide—peripheral nervous system neoplasm	0.000784	0.000912	CcSEcCtD
Oxymorphone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000777	0.000903	CcSEcCtD
Oxymorphone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000775	0.000901	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000757	0.00088	CcSEcCtD
Oxymorphone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000756	0.000879	CcSEcCtD
Oxymorphone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000753	0.000875	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.000872	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00075	0.000872	CcSEcCtD
Oxymorphone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000749	0.00087	CcSEcCtD
Oxymorphone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000747	0.000868	CcSEcCtD
Oxymorphone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00074	0.00086	CcSEcCtD
Oxymorphone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000738	0.000857	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000737	0.000856	CcSEcCtD
Oxymorphone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000736	0.000856	CcSEcCtD
Oxymorphone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000729	0.000847	CcSEcCtD
Oxymorphone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000725	0.000843	CcSEcCtD
Oxymorphone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000725	0.000843	CcSEcCtD
Oxymorphone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00072	0.000837	CcSEcCtD
Oxymorphone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000718	0.000835	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000715	0.000831	CcSEcCtD
Oxymorphone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000713	0.000829	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000709	0.000825	CcSEcCtD
Oxymorphone—Headache—Vincristine—peripheral nervous system neoplasm	0.000709	0.000825	CcSEcCtD
Oxymorphone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000698	0.000811	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000697	0.000811	CcSEcCtD
Oxymorphone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000685	0.000796	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000682	0.000792	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000676	0.000786	CcSEcCtD
Oxymorphone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000676	0.000786	CcSEcCtD
Oxymorphone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000673	0.000782	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000672	0.000781	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000672	0.000781	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.000769	CcSEcCtD
Oxymorphone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000658	0.000765	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000657	0.000763	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000656	0.000763	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000654	0.00076	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000652	0.000758	CcSEcCtD
Oxymorphone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000649	0.000754	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.00075	CcSEcCtD
Oxymorphone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000637	0.00074	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000634	0.000737	CcSEcCtD
Oxymorphone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000631	0.000733	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00063	0.000732	CcSEcCtD
Oxymorphone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000628	0.00073	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000626	0.000727	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.000722	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.000722	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000621	0.000722	CcSEcCtD
Oxymorphone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000618	0.000719	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000612	0.000711	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000706	CcSEcCtD
Oxymorphone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000607	0.000705	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000605	0.000703	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000604	0.000702	CcSEcCtD
Oxymorphone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000595	0.000691	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000594	0.00069	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000587	0.000682	CcSEcCtD
Oxymorphone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000583	0.000678	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000678	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000579	0.000673	CcSEcCtD
Oxymorphone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000578	0.000672	CcSEcCtD
Oxymorphone—Headache—Etoposide—peripheral nervous system neoplasm	0.000575	0.000668	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.000668	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.000665	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.000658	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000566	0.000658	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000565	0.000657	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000557	0.000647	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000644	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000639	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000546	0.000634	CcSEcCtD
Oxymorphone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000545	0.000633	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000544	0.000632	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000623	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000623	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000621	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000533	0.000619	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000525	0.00061	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000609	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.000608	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000603	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000599	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000598	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000596	CcSEcCtD
Oxymorphone—Shock—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000588	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000587	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000586	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.000585	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000583	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000581	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000578	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000577	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000575	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000573	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00057	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000564	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00048	0.000558	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000558	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000553	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000544	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000542	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000541	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.00054	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000537	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000535	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000458	0.000533	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000457	0.000531	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000527	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000526	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000447	0.00052	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000517	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000516	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000515	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00044	0.000511	CcSEcCtD
Oxymorphone—Pain—Epirubicin—peripheral nervous system neoplasm	0.00044	0.000511	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.0005	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000493	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000493	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000492	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000489	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000487	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000481	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000477	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000477	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000475	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000473	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000473	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000406	0.000472	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000406	0.000472	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000456	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000452	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000379	0.00044	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000439	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000437	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000437	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000429	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000423	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000409	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000407	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000397	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000395	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000391	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000327	0.00038	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000378	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000376	CcSEcCtD
Oxymorphone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000374	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000366	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000355	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000352	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000348	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000346	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000328	CcSEcCtD
